$9,01
▼ $-0,09
(-0,99%)
Vol. 135K
5
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$186.1M
ROE
-84,5%
Margine
-93,0%
D/E
102,91
Beta
1,23
52W
$4–$19
Consenso Wall Street
13 analisti · Apr 20263
Acquisto forte
8
Compra
1
Mantieni
1
Vendi
0
Vendita forte
84,6%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-0,45 | $-0,46 | $-0,01 |
| Set 2025 | $-0,51 | $-0,49 | +$0,02 |
| Giu 2025 | $-0,53 | $-0,57 | $-0,04 |
| Mar 2025 | $-0,58 | $-0,53 | +$0,05 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $15.3M | $12.3M | $13.6M | $14.7M | $16.0M |
| Utile netto | -$10.7M | -$13.8M | -$14.7M | -$12.9M | -$11.9M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.3% | -79.3% | -79.3% | -79.3% | -84.5% | -84.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -108.4% | -95.6% | -95.6% | -95.6% | -93.0% | -93.0% |
| Gross Margin | 84.3% | 83.5% | 83.5% | 83.5% | 84.5% | 84.5% |
| D/E Ratio | 85.26 | 85.26 | 85.26 | 85.26 | 102.91 | 102.91 |
| Current Ratio | 11.99 | 11.99 | 11.99 | 11.99 | 9.62 | 9.62 |
Rapporti chiave
ROA (TTM)
-42,1%
P/S (TTM)
3,32
P/B
4,3
EPS (TTM)
$-2,02
CF/Share
$-2,03
Crescita ricavi 3A
+57,9%
52W High
$18,55
52W Low
$4,30
$4,30
Intervallo 52 settimane
$18,55
Salute finanziaria
Flusso di cassa libero
-$9.8M
Debito netto
-$25.2M
Liquidità
$75.7M
Debito totale
$50.5M
Aggiornato al Dic 31, 2025
Як CVRX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка CVRX vs аналоги Health Care
P/E
—
▼
0%
sotto
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
3,3
▲
29%
sopra
peer
(2,6)
vs Peer
vs Settore
Più costoso
P/B
4,3
▲
56%
sopra
peer
(2,8)
vs Peer
vs Settore
Più costoso
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість CVRX vs аналоги Health Care
ROE
-84,5%
▼
119%
sotto
peer
(-38,5%)
vs Peer
vs Settore
Debole
Net margin
-93,0%
▼
276%
sotto
peer
(-24,7%)
vs Peer
vs Settore
Debole
Валова маржа
84,5%
▲
60%
sopra
peer
(52,9%)
vs Peer
vs Settore
Top livello
ROA
-42,1%
▼
98%
sotto
peer
(-21,2%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя CVRX vs аналоги Health Care
D/E ratio
102,9
▲
434%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
9,6
▲
345%
sopra
peer
(2,2)
vs Peer
vs Settore
Liquidità forte
Beta
1,2
▲
17%
sopra
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів CVRX
CVRX
Mediana peer
Industria
CVRX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CVRX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
HYKES KEVIN
Chief Executive Officer · Mar 02
7763 shs
VERRASTRO PAUL
Officer · Mar 02
1284 shs
OASHEIM JARED
Chief Financial Officer · Mar 02
1744 shs
JOHN ROBERT ALLEN
Officer · Mar 02
3964 shs
ADAMSON PHILIP B.
Officer · Mar 02
1262 shs
MORRISON GREGORY
Officer · Mar 02
34000 shs
HYKES KEVIN
Chief Executive Officer · Feb 27
159000 shs
BINKOWSKI BRENT
Chief Operating Officer · Feb 27
15000 shs
VERRASTRO PAUL
Officer · Feb 27
45000 shs
OASHEIM JARED
Chief Financial Officer · Feb 27
61000 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 35,12%Johnson & Johnson
15,30%
$35.9M
NEA Management Company, LLC
7,70%
$18.1M
Vanguard Group Inc
4,26%
$10.0M
Blackrock Inc.
4,03%
$9.5M
GSK plc
3,83%
$9.0M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora